
Gat Pharmaceuticals Private Limited
Pharmaceutical company involved in trading, manufacturing, and distribution of drugs, medicines, and chemicals.
Pharmaceutical company involved in trading, manufacturing, and distribution of drugs, medicines, and chemicals.
Gat Pharmaceuticals Private Limited (GPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 13 October 2016 (Eight years and six months 28 days old ). Its registered office is in Chandigarh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹1.20 M.
Gajender Singh and Ashish Pundir serve as directors at the Company.
Chandigarh, India
+91-XXXXXXXXXX
U74999CH2016PTC041251
041251
Private Limited Indian Non-Government Company
13 Oct 2016
30 Sep 2022
31 Mar 2022
Unlisted
Roc Chandigarh
Gat Pharmaceuticals Private Limited offers a wide range of products and services, including Pharma Franchise, Pharmaceutical Distributors, Aceclofenac Tablet, Aceclofenac Paracetamol Serratiopeptidase Tablet, Antibacterial Drugs, Ofloxacin Ornidazole Tablets, Ofloxacin Tablet IP, Pain Reliever Gel, Diclofenac Diethylamine Gel, Antihistamines.
Name | Designation | Appointment Date | Status |
---|---|---|---|
Gajender Singh ![]() | Director | 13-Oct-2016 | Current |
Ashish Pundir ![]() | Director | 13-Oct-2016 | Current |
Gat Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
In 2017, Gat Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Gajender Singh is a mutual person
Gajender Singh is a mutual person
Gajender Singh is a mutual person
₹1.20 M
₹0
Date | Lender | Amount | Status |
---|---|---|---|
17 Sep 2018 | Syndicate Bank | ₹0.30 M | Open |
20 Jan 2017 | Syndicate Bank | ₹0.90 M | Open |
Unlock and access historical data on people associated with Gat Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Gat Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gat Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Gat Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
Gat Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Chandigarh.
A charge with Syndicate Bank amounted to Rs. 0.30 M with Charge ID 100208589 was registered on 17 Sep 2018.
A charge with Syndicate Bank amounted to Rs. 0.90 M with Charge ID 100125903 was registered on 20 Jan 2017.
Gajender Singh was appointed as a Director was appointed as a Director on 13 Oct 2016 & has been associated with this company since 8 years 6 months .
Ashish Pundir was appointed as a Director was appointed as a Director on 13 Oct 2016 & has been associated with this company since 8 years 6 months .
Gat Pharmaceuticals Private Limited was incorporated on 13 Oct 2016.
The authorized share capital of Gat Pharmaceuticals Private Limited is ₹ 1.00 M and paid-up capital is ₹ 1.00 M.
Currently 2 directors are associated with Gat Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Gat Pharmaceuticals Private Limited is First Floor Shop No. 1139/14 Govindpura India, Manimajra, Chandigarh, 160101.
The corporate identification number (CIN) of Gat Pharmaceuticals Private Limited is U74999CH2016PTC041251 and the company number is 041251 as per Ministry of Corporate Affairs (MCA).
As per the financial statements for fiscal Year 2017, The total open charges for Gat Pharmaceuticals Private Limited amount to ₹ 1.20 M.
The most recent Balance Sheet for Gat Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2022.
Search company & director profiles for free and gain access to critical business data.
TC